Craig-Hallum Downgrades Joint to Hold, Announces $30 Price Target
Craig-Hallum analyst Jeremy Hamblin downgrades Joint (NASDAQ:JYNT) from Buy to Hold and announces $30 price target.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
The Joint Corp. Acquires Northern California Regional Developer Territory For $2.4M
Expected to increase margin contribution and support corporate clinic growth opportunity
SCOTTSDALE, Ariz., April 06, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of
The Joint Corp. Acquires Northeast Regional Developer Territory
- Expands Corporate Clinic Opportunity in the Northeast Region -
SCOTTSDALE, Ariz., March 23, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
93 Biggest Movers From Friday
Gainers
Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.
45 Stocks Moving In Friday’s Mid-Day Session
Gainers
KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral.